What are the differential diagnoses for focal patchy alopecia with vertex thinning in 17‑20‑year‑old female patients without a family history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnoses for Focal Patchy Alopecia with Vertex Thinning in Young Women

Your patients most likely have alopecia areata presenting with an atypical diffuse pattern, but you must systematically exclude telogen effluvium, early female pattern hair loss (FPHL), trichotillomania, tinea capitis, early scarring alopecias, and less commonly systemic lupus erythematosus or secondary syphilis 1.

Primary Diagnostic Considerations

1. Alopecia Areata (Most Likely)

The combination of focal patchy loss with diffuse thinning suggests alopecia areata with both patchy and diffuse components. While AA classically presents as circumscribed patches, it can manifest with diffuse hair loss that is difficult to diagnose 1.

Key diagnostic features to look for:

  • Exclamation mark hairs at the margins of patches (short broken hairs with tapered proximal ends)
  • Positive hair pull test in active areas
  • Preserved follicular ostia on examination
  • Dermoscopy findings: yellow dots (empty follicles), black dots, broken hairs, and tapering hairs 1
  • Nail involvement in ~10% (pitting, trachyonychia)
  • Slightly reddened but otherwise normal-appearing skin

Important caveat: The absence of family history does NOT exclude AA—only 20% have positive family history 1. The age range (17-20 years) fits perfectly as most AA patients present before age 30 2.

2. Telogen Effluvium (Critical to Exclude)

This is the most important differential when diffuse thinning accompanies patchy loss 1.

Distinguishing features:

  • Diffuse shedding across entire scalp including occiput (not just vertex)
  • Positive hair pull test from multiple areas including occipital region
  • History of triggering event 2-4 months prior (stress, illness, medication, nutritional deficiency)
  • No true "bald patches"—just overall decreased density
  • Scalp biopsy shows terminal-to-vellus ratio of 9:1 (no miniaturization) vs. <1.7:1 in pattern hair loss 3

3. Early Female Pattern Hair Loss (FPHL)

Less likely given the age and focal patches, but FPHL can coexist with other conditions 3.

Look for:

  • Central/vertex thinning with preserved frontal hairline (Ludwig pattern)
  • Increased variability in hair shaft diameter
  • Dermoscopy: increased single hair units, peripilar hyperpigmentation (86% of cases), yellow dots 3
  • Gradual onset over months to years
  • Biopsy shows terminal-to-vellus ratio <3:1 with miniaturization 3

4. Trichotillomania

The BAD guidelines note this "probably causes most confusion" with AA and may coexist 1.

Distinguishing features:

  • Incomplete hair loss within patches (not completely bald)
  • Broken hairs are firmly anchored and remain in anagen phase (unlike exclamation mark hairs)
  • Irregular, bizarre-shaped patches
  • Patient may deny hair pulling
  • Dermoscopy shows broken hairs at different lengths, coiled hairs, flame hairs

5. Tinea Capitis

Must be excluded, especially given the age group 1.

Look for:

  • Scalp inflammation (may be subtle)
  • Scaling, erythema
  • Black dots (broken hairs at scalp surface)
  • Perform fungal culture/KOH prep if any suspicion

6. Early Scarring Alopecias

Critical not to miss as these are irreversible 1.

Specific entities to consider:

  • Central Centrifugal Cicatricial Alopecia (CCCA): Central/vertex predominant, primarily in African American women, leads to loss of follicular ostia 3
  • Frontal Fibrosing Alopecia (FFA): Receding hairline with perifollicular erythema, eyebrow loss, primarily postmenopausal but can occur in younger women 3
  • Lichen Planopilaris: Perifollicular erythema and scale
  • Look for: Loss of follicular ostia, perifollicular erythema/scale, scarring

7. Systemic Lupus Erythematosus & Secondary Syphilis

Less common but must be considered in young women 1.

Diagnostic Algorithm

Step 1: Clinical Examination

  • Examine hair pull test at patches AND vertex AND occiput
  • Look for exclamation mark hairs at patch margins
  • Check for follicular ostia preservation
  • Examine for scalp inflammation, scaling, erythema
  • Check nails for pitting
  • Examine eyebrows and body hair

Step 2: Dermoscopy

  • Yellow dots, black dots, broken hairs → AA
  • Peripilar hyperpigmentation, single hair units → FPHL
  • Loss of follicular ostia, perifollicular erythema → scarring alopecia

Step 3: Targeted Testing

  • If diagnosis unclear: 4mm punch biopsy (two specimens—one for horizontal sectioning, one for vertical sectioning and DIF if scarring suspected) 1, 3
  • If tinea suspected: Fungal culture
  • If lupus suspected: ANA, anti-dsDNA, serology
  • If syphilis suspected: RPR/VDRL

Step 4: Investigations NOT Routinely Needed

  • Thyroid function, autoimmune screening NOT recommended routinely for AA 1
  • Iron studies NOT recommended routinely (conflicting evidence on association) 1

Most Likely Scenario

Given focal patches PLUS vertex thinning in young women without family history, this most likely represents alopecia areata with both patchy and diffuse components. The vertex thinning may represent either:

  1. Diffuse alopecia areata pattern
  2. Coexistent telogen effluvium triggered by the stress of AA
  3. Early progression toward more extensive AA

Immediate action: Perform dermoscopy looking for yellow dots and exclamation mark hairs. If present, diagnose AA. If absent or atypical features present (inflammation, scarring, firmly anchored broken hairs), proceed to biopsy to exclude other diagnoses, particularly scarring alopecias which require urgent different management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.